# Vedolizumab (Genetical Recombination) S.C. Injection 108mg Syringe (エンタイビオ皮下注１０８ｍｇシリンジ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 2399405G1025). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 2399405G1025
- **Product name (Japanese):** エンタイビオ皮下注１０８ｍｇシリンジ
- **English title:** Vedolizumab (Genetical Recombination) S.C. Injection 108mg Syringe
- **Active ingredient:** ベドリズマブ（遺伝子組換え）
- **Active ingredient (INN):** Vedolizumab (Genetical Recombination)
- **Strength / unit:** １０８ｍｇ０．６８ｍＬ１筒
- **Route:** Injection (注射薬)
- **Therapeutic category:** 23 Digestive organ agents (消化器官用薬) › 239 Other digestive organ agents (その他の消化器官用薬)
- **Manufacturer:** Takeda Pharmaceutical (武田薬品工業)
- **NHI price (reference only):** JPY 69888 per １０８ｍｇ０．６８ｍＬ１筒
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/2399405G1025
- **JSON:** https://www.nifujipharma.com/api/drugs/2399405G1025

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Vedolizumab%20(Genetical%20Recombination)%20S.C.%20Injection%20108mg%20Syringe%20(%E3%82%A8%E3%83%B3%E3%82%BF%E3%82%A4%E3%83%93%E3%82%AA%E7%9A%AE%E4%B8%8B%E6%B3%A8%EF%BC%91%EF%BC%90%EF%BC%98%EF%BD%8D%EF%BD%87%E3%82%B7%E3%83%AA%E3%83%B3%E3%82%B8)%20%2F%20YJ%202399405G1025#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Vedolizumab (Genetical Recombination)

- [Vedolizumab (Genetical Recombination) for I.V. Infusion 300mg (エンタイビオ点滴静注用３００ｍｇ)](https://www.nifujipharma.com/drugs/2399405F1020) — ３００ｍｇ１瓶, Takeda Pharmaceutical
- [Vedolizumab (Genetical Recombination) S.C. Injection 108mg Pen (エンタイビオ皮下注１０８ｍｇペン)](https://www.nifujipharma.com/drugs/2399405G2021) — １０８ｍｇ０．６８ｍＬ１キット, Takeda Pharmaceutical